0001295524-15-000002.txt : 20150630 0001295524-15-000002.hdr.sgml : 20150630 20150630164356 ACCESSION NUMBER: 0001295524-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 EFFECTIVENESS DATE: 20150630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmatrix Operating Company, Inc. CENTRAL INDEX KEY: 0001295524 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-242824 FILM NUMBER: 15961836 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-2333 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Pulmatrix Inc DATE OF NAME CHANGE: 20040625 D 1 primary_doc.xml X0707 D LIVE 0001295524 Pulmatrix Operating Company, Inc. 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA MASSACHUSETTS 02421 (781) 357-2333 DELAWARE Pulmatrix Inc Corporation true Robert Clarke 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Chief Executive Officer and Member of the Board of Directors David Hava 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Executive Officer Chief Scientific Officer Robert Connelly 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director David Edwards 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Steven Gillis 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Kurt Graves 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Michael Higgins 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director David Maki 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Terrance McGuire 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Scott Rocklage 99 Hayden Avenue Suite 390 Lexington MA MASSACHUSETTS 02421 Director Pharmaceuticals Decline to Disclose 06b false 2015-06-15 false true true true The offering was made in connection with, and was cross-conditioned with the closing of, a merger between Pulmatrix Operating Company, Inc. and Pulmatrix, Inc. 0 34124543 10000000 24124543 The total offering amount includes (i) $10,000,000, representing the aggregate gross proceeds from the offering and (ii) $24,124,543, representing the total aggregate exercise price of warrants issued in the offering. false 11 0 0 0 false Pulmatrix Operating Company, Inc. /s/ Michelle S. Siegert Michelle S. Siegert Assistant Secretary 2015-06-30